Subscribe to RSS
DOI: 10.1055/s-0043-1771025
Individualized Homeopathic Medicines in the Treatment of Knee Osteoarthritis: Double-Blind, Randomized, Placebo-Controlled Feasibility Trial
Funding None.Abstract
Introduction This study aimed at examining the feasibility issues of comparing individualized homeopathic medicines (IHMs) with identical-looking placebos for treating knee osteoarthritis (OA).
Methods Forty eligible patients participated in this double-blind, randomized (1:1), placebo-controlled feasibility trial in the outpatient clinics of a homeopathic hospital in West Bengal, India. Either IHMs or identical-looking placebos were administered, along with mutually agreed-upon concomitant care guidelines. The Knee Injury and Osteoarthritis Outcome Score (KOOS) was the primary outcome measure, along with derived Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores from KOOS. The EQ-5D-5L questionnaire and Visual Analog Scale (VAS) were the secondary outcomes. All were measured at baseline and after 2 months. Group differences and effect sizes (Cohen's d) were estimated using an intention-to-treat approach. p-Values less than 0.05 (two-tailed) were considered statistically significant.
Results Enrolment/screening and trial retention rates were 43% and 85% respectively. Recruitment was difficult owing to the coronavirus disease 2019 (COVID-19) lockdown. Group differences were statistically significant, favoring IHMs against placebos in all the KOOS sub-scales: symptoms (p < 0.001), pain (p = 0.002), activities of daily living (p < 0.001), sports or recreation (p = 0.016), and quality of life (p = 0.002). Derived WOMAC scores from KOOS favored IHMs against placebos: stiffness (p < 0.001) and pain (p < 0.001). The EQ-5D-5L questionnaire score (p < 0.001) and EQ-5D-5L VAS scores (p < 0.001) also yielded significant results, favoring IHMs over placebos. All the effect sizes ranged from moderate to large. Sulphur was the most frequently prescribed homeopathic medication. Neither group reported any harm or serious adverse events.
Conclusion Although recruitment was sub-optimal due to prevailing COVID-19 conditions during the trial, the action of IHMs was found to be superior to that of placebos in the treatment of knee OA. Larger and more definitive studies, with independent replications, are warranted in order to substantiate the findings.
Trial registration: CTRI/2021/02/031453.
Data Availability
All the findings of the study are available from the corresponding author upon reasonable request.
Authors' Contributions
S.B., C.C., S.S., S.N., P.B., S.M.A., P.G. and S.K.M.: concept and literature search. S.B., C.C., S.S., S.N., P.B., S.M.A., S.A., A.R.S. and P.G.: clinical study and data acquisition. S. Saha, P.G. and M.K.: data interpretation, statistical analysis, and preparation of the article. All the authors reviewed and approved the final article.
Publication History
Received: 18 March 2023
Accepted: 09 May 2023
Article published online:
25 September 2023
© 2023. Faculty of Homeopathy. This article is published by Thieme.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Munjal YP. ed. The Association of Physicians of India. Vol 2. 10th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2015: 2479
- 2 Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 2020; 29-30: 100587
- 3 Jaiswal A, Goswami K, Haldar P, Salve HR, Singh U. Prevalence of knee osteoarthritis, its determinants, and impact on the quality of life in elderly persons in rural Ballabgarh, Haryana. J Family Med Prim Care 2021; 10: 354-360
- 4 Zamri N, Harith S, Mat-Hassan N, Ong YQ. Nutritional status and health-related quality of life among knee and hip osteoarthritis patients under rehabilitation care in Kuala Nerus, Terengganu, Malaysia. Malays Orthop J 2021; 15: 77-88
- 5 Abbott JH, Usiskin IM, Wilson R, Hansen P, Losina E. The quality-of-life burden of knee osteoarthritis in New Zealand adults: a model-based evaluation. PLoS One 2017; 12: e0185676
- 6 Richards MM, Maxwell JS, Weng L, Angelos MG, Golzarian J. Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed 2016; 44: 101-108
- 7 Teymouri S, Rakhshandeh H, Baghdar HN, Yousefi M, Salari R. Analgesic herbal medicines in the treatment of knee osteoarthritis: a systematic review. Curr Rheumatol Rev 2019; 15: 290-303
- 8 Ginnerup-Nielsen EM, Henriksen M, Christensen R. et al. Prevalence of self-reported knee symptoms and management strategies among elderly individuals from Frederiksberg municipality: protocol for a prospective and pragmatic Danish cohort study. BMJ Open 2019; 9: e028087
- 9 Gregori D, Giacovelli G, Minto C. et al. Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis. JAMA 2018; 320: 2564-2579
- 10 Lee T, Lu N, Felson DT. et al. Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study. Rheumatology (Oxford) 2016; 55: 1099-1105
- 11 Kolasinski SL, Neogi T, Hochberg MC. et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2020; 72: 149-162
- 12 Long L, Ernst E. Homeopathic remedies for the treatment of osteoarthritis: a systematic review. Br Homeopath J 2001; 90: 37-43
- 13 Koley M, Saha S, Medhurst R. Clinical trials of homoeopathy in osteoarthritis: a systematic review. OA Alternative Medicine 2013; 1: 24
- 14 Shealy CN, Thomlinson RP, Cox RH. et al. Osteoarthritic pain: a comparison of homoeopathy and acetaminophen. Am J Pain Manage 1998; 8: 89-91
- 15 van Haselen RA, Fisher PA. A randomized controlled trial comparing topical piroxicam gel with a homeopathic gel in osteoarthritis of the knee. Rheumatology (Oxford) 2000; 39: 714-719
- 16 Maronna U, Weiser M, Klein P. Oral treatment of osteoarthritis of the knee with Zeel comp. – results of a double-blind equivalence study versus diclofenac. Biol Med 2000; 29: 157-158
- 17 Strösser W, Weiser M. Patienten mit Gonarthrose gewinnen ihre Mobilität zurϋck. Homöopathikum im Doppel-blind-Vergleich. [Patients with gonarthrosis gaining back mobility – a double-blind comparison of homeopathy]. Biol Med 2000; 29: 295-299
- 18 Koley M, Saha S, Ghosh S. A double-blind randomized placebo-controlled feasibility study evaluating individualized homeopathy in managing pain of knee osteoarthritis. J Evid Based Complementary Altern Med 2015; 20: 186-191
- 19 Motiwala FF, Kundu T, Bagmar K. et al. Effect of homoeopathic treatment on activity of daily living (ADL) in knee osteoarthritis: a prospective observational study. Indian J Res Homoeopathy 2016; 10: 182-187
- 20 World Medical Association.. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 2001; 79: 373-374
- 21 Altman R, Asch E, Bloch D. et al; Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-1049
- 22 Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS) – development of a self-administered outcome measure. J Orthop Sports Phys Ther 1998; 28: 88-96
- 23 Roos EM, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) – validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes 2003; 1: 17
- 24 Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes 2003; 1: 64
- 25 The Euro-QOL group. . EQ-5D–5L 2019 . Accessed November 6, 2020 at: http://www.euroqol.org/eq-5d-products/eq-5d-5l.html
- 26 Herdman M, Gudex C, Lloyd A. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20: 1727-1736
- 27 Eldridge SM, Chan CL, Campbell MJ. et al; PAFS Consensus Group. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ 2016; 355: i5239
- 28 Dean ME, Coulter MK, Fisher P, Jobst K, Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Homeopathy 2007; 96: 42-45
- 29 Hering C. The Homoeopathic Domestic Physician, 11th American ed. Philadelphia: Boericke & Tafel; 1904: 414
- 30 Burt WMH. Physiological Materia Medica. 5th ed. Chicago: Gross & Delbridge Co.; 1896: 899
- 31 Saha S, Koley M, Ghosh S, Giri M, Das A, Goenka R. Documentation of prescriptions and clinical outcomes in a homeopathic hospital setting in West Bengal, India. J Evid Based Complementary Altern Med 2015; 20: 180-185
- 32 Kumar NR, Iyer NH. An observational study on the effect of individualized homoeopathic medicine administered based on totality of symptoms vis-à-vis personality in cases of osteoarthritis knee. Indian J Res Homoeopathy 2021; 15: 103-112